Crossmark

Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients naïve to anti-TNF therapy

Crossref DOI link: https://doi.org/10.1007/s10067-019-04509-1

Published Online: 2019-03-25

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Reyes-Loyola, Paola

Rodríguez-Henríquez, Pedro

Ballinas-Verdugo, Martha A.

Amezcua-Castillo, Luis M.

Juárez-Vicuña, Yaneli

Jiménez-Rojas, Valentín

Márquez-Velasco, Ricardo

Sánchez-Muñoz, Fausto

Amezcua-Guerra, Luis M. https://orcid.org/0000-0002-6258-5732
License Information

Text and Data Mining valid from 2019-03-25
More Information

Article History

Received: 24 August 2018

Revised: 25 January 2019

Accepted: 10 February 2019

First Online: 25 March 2019

Compliance with ethical standards

: All human studies were approved by the local ethics committee and were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons gave their informed consent prior to their inclusion in the study.

: None.

Document is current

Any future updates will be listed below